{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[5,2,5,3],[13,2,13,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910690658903321"]
[null,null,"Titolo",null,"Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"[Rockville, Md.] : , : [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], , [1999]"]
[null,null,"Collana",null,"Evidence report/technology assessment. Summary ; ; no. 4"]
[{"$nulls":4},"AHCPR publication ; ; no. 99-E011"]
[null,null,"Soggetti",null,"Prostate - Cancer - Hormone therapy"]
[{"$nulls":4},"Antiandrogens - Therapeutic use"]
[{"$nulls":4},"Androgen Antagonists - therapeutic use"]
[{"$nulls":4},"Cost-Benefit Analysis"]
[{"$nulls":4},"Gonadotropin-Releasing Hormone - antagonists & inhibitors"]
[{"$nulls":4},"Outcome Assessment, Health Care"]
[{"$nulls":4},"Prostatic Neoplasms - drug therapy"]
[{"$nulls":4},"Randomized Controlled Trials as Topic"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Title from title screen (viewed on Apr. 29, 2004)."]
[{"$nulls":4},"\"January 1999.\""]
[{"$nulls":4},"\"The full evidence report from which this summary was taken was prepared by the Evaluation Technology Center, an AHCPR Evidence-based Practice Center of the Blue Cross and Blue Shield Association, Chicago, Illinois, under contract no. 290-97-0015.\""]